Abstract
Rheumatic diseases (RDs) include a variety of autoimmune disorders defined by severe inflammation, primarily affecting the joints, tendons, ligaments, bones, and muscles. Recent research has revealed the association between rheumatic diseases and gut microbiota, thereby providing insights into the underlying mechanisms of disease pathogenesis. The objective of this study was to evaluate the quantity and quality of scientific research regarding the association between RDs and gut microbiota, as well as to elucidate the characteristics of worldwide research output in this field. The present bibliometric analysis was carried out using the Scopus database, using the keywords "rheumatology," "arthritis," and "gut microbiota." The study involved determining the number of articles, the number of active countries with journals, the identification of prolific authors, and the collection of citation data. Additionally, analyses of trends were conducted. 503 articles in all were reviewed. Collaboration networks were visualized using mapping techniques. The number of articles on RDs and gut microbiota exhibited a consistent pattern from 2002 to 2022 (p < 0.05). The five most productive countries were China (n = 128; 25.45%), the United States (n = 101; 20.07%), Italy (n = 40; 7.95%), the United Kingdom (n = 20; 3.98%), and Japan (n = 17; 3.38%). Israel, Italy, Belgium, and Portugal had the highest values regarding the number of articles per million population. Australia, Canada, and the United Kingdom were the top three countries regarding average citation count. This bibliometric analysis evaluates and synthesizes global scientific output on RDs and gut microbiota. The literature on the association between rheumatic diseases and gut microbiota is growing. Supporting researchers in countries with limited involvement in this field will contribute to its growth.
Similar content being viewed by others
Data availability
The supply of raw data is available upon request.
References
Ostrov BE, Amsterdam D (2017) Immunomodulatory interplay of the microbiome and therapy of rheumatic diseases. Immunol Invest 46(8):769–792
Phang JK, Kwan YH, Goh H, Tan VIC, Thumboo J, Østbye T, Fong W (2018) Complementary and alternative medicine for rheumatic diseases: a systematic review of randomized controlled trials. Complement Ther Med 37:143–157
Kocyigit BF, Sagtaganov Z, Yessirkepov M, Akyol A (2022) Assessment of complementary and alternative medicine methods in the management of ankylosing spondylitis, rheumatoid arthritis, and fibromyalgia syndrome. Rheumatol Int 43:1–9
Bao Y, Dong C, Ji J, Gu Z (2020) Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases. Clin Rheumatol 39:2523–2528
Kato M, Yasuda S, Atsumi T (2018) The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at? Rheumatol Int 38(8):1333–1338
Cooper C, Chapurlat R, Al-Daghri N, Herrero-Beaumont G, Bruyère O, Rannou F, Roth R, Uebelhart D, Reginster J-Y (2019) Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: what does the literature say? Drugs Aging 36(Suppl 1):15–24
Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron J, Bombardier C, Cannon C, Farkouh M, FitzGerald G (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (London, England) 382(9894):769–779
Zhong D, Wu C, Zeng X, Wang Q (2018) The role of gut microbiota in the pathogenesis of rheumatic diseases. Clin Rheumatol 37:25–34
Wang Y, Wei J, Zhang W, Doherty M, Zhang Y, Xie H, Li W, Wang N, Lei G, Zeng C (2022) Gut dysbiosis in rheumatic diseases: a systematic review and meta-analysis of 92 observational studies. EBioMedicine 80:104055
Rosenbaum JT, Asquith MJ (2016) The microbiome: a revolution in treatment for rheumatic diseases? Curr Rheumatol Rep 18:1–7
Rosser EC, Mauri C (2016) A clinical update on the significance of the gut microbiota in systemic autoimmunity. J Autoimmun 74:85–93
Koboziev I, Webb CR, Furr KL, Grisham MB (2014) Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radical Biol Med 68:122–133
Pianta A, Arvikar S, Strle K, Drouin EE, Wang Q, Costello CE, Steere AC (2017) Evidence of the immune relevance of Prevotella copri, a gut microbe, in patients with rheumatoid arthritis. Arthritis Rheumatol 69(5):964–975
Tejesvi M, Arvonen M, Kangas S, Keskitalo P, Pirttilä A, Karttunen T, Vähäsalo P (2016) Faecal microbiome in new-onset juvenile idiopathic arthritis. Eur J Clin Microbiol Infect Dis 35(3):363–370
Tan L, Zhao S, Zhu W, Wu L, Li J, Shen M, Lei L, Chen X, Peng C (2018) The Akkermansia muciniphila is a gut microbiota signature in psoriasis. Exp Dermatol 27(2):144–149
Bazin T, Hooks KB, Barnetche T, Truchetet M-E, Enaud R, Richez C, Dougados M, Hubert C, Barré A, Nikolski M (2018) Microbiota composition may predict anti-TNF alpha response in spondyloarthritis patients: an exploratory study. Sci Rep 8(1):5446
Stoll ML, Weiss PF, Weiss JE, Nigrovic PA, Edelheit BS, Bridges SL, Danila MI, Spencer CH, Punaro MG, Schikler K (2018) Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther 20:1–10
Kutluk MG, Danis A (2021) Bibliometric analysis of publications on pediatric epilepsy between 1980 and 2018. Childs Nerv Syst 37:617–626
Roemer RC, Borchardt R (2015) Meaningful metrics: A 21st century librarian’s guide to bibliometrics, altmetrics, and research impact. Amer Library Assn
Rojas-Sánchez MA, Palos-Sánchez PR, Folgado-Fernández JA (2023) Systematic literature review and bibliometric analysis on virtual reality and education. Educ Inf Technol 28(1):155–192
Huang R, Zhang M, Lu Y, Xu D, Liu Y, Jin M, Xian S, Wang S, Tong X, Lu J (2022) Effects of intestinal microbes on rheumatic diseases: a bibliometric analysis. Front Microbiol 13
Sweileh WM (2018) Research trends on human trafficking: a bibliometric analysis using Scopus database. Glob Health 14:1–12
Villalobos D, Povedano-Montero J, Fernández S, López-Muñoz F, Pacios J, del Río D (2022) Scientific research on verbal fluency tests: a bibliometric analysis. J Neurolinguist 63:101082
Redondo M, Leon L, Povedano FJ, Abasolo L, Perez-Nieto MA, López-Muñoz F (2017) A bibliometric study of the scientific publications on patient-reported outcomes in rheumatology. In: Semin Arthritis Rheum. Elsevier, pp 828–833
Kokol P, Blažun Vošner H, Završnik J (2021) Application of bibliometrics in medicine: a historical bibliometrics analysis. Health Info Libr J 38(2):125–138
Kocyigit BF, Akyol A (2021) Bibliometric analysis of publication activity in the field of familial Mediterranean fever in 2010–2019: a Scopus-based study. Rheumatol Int 41(11):2015–2023
Gao S, Meng F, Gu Z, Liu Z, Farrukh M (2021) Mapping and clustering analysis on environmental, social and governance field a bibliometric analysis using Scopus. Sustainability 13(13):7304
Zhao X, Chen J, Pan Y, Feng H, Meng B, Meng Y (2019) A bibliometric analysis of the global research in ankylosing spondyloarthritis (2008–2017). Rheumatol Int 39(6):1091–1097
Mörschbächer AP, Granada CE (2022) Mapping the worldwide knowledge of antimicrobial substances produced by Lactobacillus spp.: a bibliometric analysis. BiochemEng J 180:108343
Al Husaeni DF, Nandiyanto ABD (2022) Bibliometric using Vosviewer with Publish or Perish (using google scholar data): from step-by-step processing for users to the practical examples in the analysis of digital learning articles in pre and post Covid-19 pandemic. ASEAN J Sci Eng 2(1):19–46
Rodríguez-Navarro A, Brito R (2022) The link between countries’ economic and scientific wealth has a complex dependence on technological activity and research policy. Scientometrics 127(5):2871–2896
Jack P, Lachman J, López A (2021) Scientific knowledge production and economic catching-up: an empirical analysis. Scientometrics 126(6):4565–4587
Huang R, Zhang M, Lu Y, Xu D, Liu Y, Jin M, Xian S, Wang S, Tong X, Lu J (2023) Effects of intestinal microbes on rheumatic diseases: a bibliometric analysis. Front Microbiol 13:1074003
Huang Z, Liu K, Ma W, Li D, Mo T, Liu Q (2022) The gut microbiome in human health and disease—where are we and where are we going? A bibliometric analysis. Front Microbiol 13:1018594
Trejo-Castro AI, Carrion-Alvarez D, Martinez-Torteya A, Rangel-Escareño C (2022) A bibliometric review on gut microbiome and alzheimer’s disease between 2012 and 2021. Front Aging Neurosci 14:804177
Zhu X, Hu J, Deng S, Tan Y, Qiu C, Zhang M, Ni X, Lu H, Wang Z, Li L (2021) Bibliometric and visual analysis of research on the links between the gut microbiota and depression from 1999 to 2019. Front Psych 11:587670
Huang X, Fan X, Ying J, Chen S (2019) Emerging trends and research foci in gastrointestinal microbiome. J Transl Med 17(1):1–11
Yuan X, Chang C, Chen X, Li K (2021) Emerging trends and focus of human gastrointestinal microbiome research from 2010–2021: a visualized study. J Transl Med 19(1):1–16
Yang S, Hao S, Wang Q, Lou Y, Jia L, Chen D (2022) The interactions between traditional Chinese medicine and gut microbiota: global research status and trends. Front Cell Infect Microbiol 12:1331
Kabeerdoss J, Sandhya P, Danda D (2016) Gut inflammation and microbiome in spondyloarthritis. Rheumatol Int 36:457–468
Méndez-Salazar EO, Martínez-Nava GA (2022) Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development. Rheumatol Int 42(3):403–412
Caminer AC, Haberman R, Scher JU (2017) Human microbiome, infections, and rheumatic disease. Clin Rheumatol 36:2645–2653
Funding
None.
Author information
Authors and Affiliations
Contributions
EK created the study. EK and TK evaluated the articles and supplied the data. EK examined the data. The analytical tools were supplied by TK. EK and TK authored and reviewed drafts of the paper. EK prepared the tables. EK and TK agreed to accept responsibility for all facets of the work and have accepted the final version as it has been presented. Both authors take full responsibility for the integrity and accuracy of all aspects of the work.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
External editing/writing
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kocyigit, E., Kocak, T. Rheumatic diseases and gut microbiota publications in 2002–2022: a Scopus‑based bibliometric analysis. Rheumatol Int 43, 2115–2124 (2023). https://doi.org/10.1007/s00296-023-05408-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-023-05408-0